| ARVs | Antiretrovirals |
| CDC | U.S. Center for Disease Control and Prevention |
| CKD | Chronic Kidney Disease |
| CYPs | Cytochromes P450 |
| DBP | Diastolic Blood Pressure |
| EsMoH | Eswatini Ministry of Health |
| HAART | Highly Active Antiretroviral Therapy |
| INH | Isonicotinylhydrazide (Isoniazid) |
| IQR | Interquartile Range |
| LFTs | Liver Function Tests |
| MDRD | Modification of Diet in Renal Disease |
| NICE | National Institute for Health and Care Excellence |
| NNRTIs | Non-nucleoside Reverse Transcriptase Inhibitors |
| NRTIs | Nucleoside Reverse Transcriptase Inhibitors |
| PAGAA | Panel on Antiretroviral Guidelines for Adults and Adolescents |
| PAHO | Pan American Health Organization |
| PEPFAR | President’s Emergency Plan for AIDS Relief |
| PIs | Protease Inhibitors |
| PLHIV | People Living with HIV |
| RFMH | Raleigh Fitkin Memorial Hospital |
| SBP | Systolic Blood Pressure |
| SHIMS | Swaziland HIV Incidence Measurement Survey |
| SNAP | Eswatini National Program |
| USAID | United States Agency for International Development |
| USDHHS | United States Department of Health of Human Services |